Search
Filter Results
- Resource Type
- Article1
- Book1
- Database1
- Article Type
- Clinical Trial1
- Clinical Study1
- Research Support, U.S. Gov't, P.H.S.1
- Result From
- Lane Catalog1
- PubMed1
-
Year
- Journal Title
- Cancer Treat Rep1
Search Results
Sort by
- DatabaseStahl, Stephen M.Summary: Comprehensive and regularly updated, providing full access to the entire current Cambridge portfolio of neuropsychopharmacology books by Dr Stahl. A one-stop shopDigital Access Database
- ArticleKomp DM, Silva-Sosa M, Miale T, Sexauer C, Herson J.Cancer Treat Rep. 1977 Aug;61(5):855-9.The overall 38% response rate in histiocytosis X for cyclophosphamide, vincristine (Oncovin), prednisone, and procarbazine was not superior to responses that can be achieved with the component single agents. This is in contrast to the higher response rates that can be achieved by the combination of these agents in Hodgkin's disease. This is the second study of combination chemotherapy with individually effective agents that has failed to improve the response rates in histiocytosis patients with poor prognostic indicators.